First Trust Direct Indexing L.P. Boosts Stake in Agilent Technologies, Inc. (NYSE:A)

First Trust Direct Indexing L.P. increased its stake in shares of Agilent Technologies, Inc. (NYSE:AFree Report) by 16.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,438 shares of the medical research company’s stock after buying an additional 888 shares during the quarter. First Trust Direct Indexing L.P.’s holdings in Agilent Technologies were worth $937,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. LPL Financial LLC lifted its stake in Agilent Technologies by 11.5% during the 3rd quarter. LPL Financial LLC now owns 57,954 shares of the medical research company’s stock valued at $6,480,000 after acquiring an additional 5,978 shares during the period. Schonfeld Strategic Advisors LLC acquired a new position in Agilent Technologies during the third quarter valued at $707,000. Advisors Asset Management Inc. boosted its holdings in Agilent Technologies by 7.3% in the third quarter. Advisors Asset Management Inc. now owns 15,358 shares of the medical research company’s stock valued at $1,717,000 after purchasing an additional 1,042 shares during the last quarter. Alps Advisors Inc. grew its position in Agilent Technologies by 95.1% during the 3rd quarter. Alps Advisors Inc. now owns 12,459 shares of the medical research company’s stock worth $1,393,000 after purchasing an additional 6,072 shares during the period. Finally, Adage Capital Partners GP L.L.C. raised its stake in shares of Agilent Technologies by 17.9% during the 3rd quarter. Adage Capital Partners GP L.L.C. now owns 196,908 shares of the medical research company’s stock valued at $22,018,000 after buying an additional 29,953 shares during the last quarter.

Analysts Set New Price Targets

A number of analysts have recently commented on A shares. Robert W. Baird lowered their target price on Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating on the stock in a research note on Thursday, May 30th. Bank of America lifted their target price on shares of Agilent Technologies from $134.00 to $140.00 and gave the company a “neutral” rating in a report on Tuesday, June 25th. Jefferies Financial Group reissued a “hold” rating and set a $135.00 price target (down from $152.00) on shares of Agilent Technologies in a report on Monday, June 3rd. Stifel Nicolaus cut their price objective on shares of Agilent Technologies from $163.00 to $151.00 and set a “buy” rating for the company in a report on Thursday, May 30th. Finally, TD Cowen decreased their price objective on shares of Agilent Technologies from $163.00 to $153.00 and set a “buy” rating for the company in a research report on Thursday, May 30th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, Agilent Technologies presently has a consensus rating of “Hold” and an average target price of $137.13.

Read Our Latest Stock Report on A

Agilent Technologies Stock Performance

Shares of NYSE:A opened at $126.13 on Friday. The business’s 50 day moving average price is $138.73 and its 200-day moving average price is $138.18. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.15 and a quick ratio of 1.64. The firm has a market capitalization of $36.80 billion, a PE ratio of 29.82, a P/E/G ratio of 4.27 and a beta of 1.05. Agilent Technologies, Inc. has a 1 year low of $96.80 and a 1 year high of $155.35.

Agilent Technologies (NYSE:AGet Free Report) last released its earnings results on Wednesday, May 29th. The medical research company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.03. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The business had revenue of $1.57 billion for the quarter, compared to analyst estimates of $1.58 billion. During the same period last year, the company posted $1.27 EPS. The business’s revenue was down 8.4% on a year-over-year basis. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 5.25 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd will be issued a $0.236 dividend. The ex-dividend date is Tuesday, July 2nd. This represents a $0.94 annualized dividend and a yield of 0.75%. Agilent Technologies’s payout ratio is 22.22%.

Insider Activity

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $130.00, for a total transaction of $254,540.00. Following the completion of the sale, the chief executive officer now owns 25,185 shares of the company’s stock, valued at $3,274,050. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of Agilent Technologies stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the completion of the sale, the senior vice president now directly owns 49,486 shares in the company, valued at $6,595,494.08. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $130.00, for a total transaction of $254,540.00. Following the completion of the transaction, the chief executive officer now owns 25,185 shares in the company, valued at $3,274,050. The disclosure for this sale can be found here.

Agilent Technologies Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Read More

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.